chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a health professional concerning a 12 year old female who on 22-NOV-2006 was vaccinated with the first dose of Gardasil (Lot # not reported). On approximately 22-NOV-2006 the patient experienced feeling light headed. on 24-JAN-2007 the patient received the second dose of Gardasil (lot # not reported). on approximately 24-JAN-2007 the patient experienced feeling light headed. on 06-JUN-2007 the patient received the third dose of Gardasil (Lot# not reported). On approximately 06-JUN-2007 the patient experienced feeling light headed and vomited. Additional information has been requested.
I had a tattoo done on Sunday night (4/18). I have had many tattoos before this. The first two days of healing went great, but I woke up on Thursday morning with horrific symptoms. Weeping fluid and ink to the point where my skin was coming off in sheets. Extreme pain, swelling and bleeding. I assumed it was an infection or an allergy, but it is not infected. I don't think it was an allergy, unless it was a mild allergy exacerbated by the vaccine. Healing has been truly terrible and I'm still on the road to recovery now.
This report as received from a physician refers to a 40 year old female patient enrolled in a study. The patient's current condition includes anxiety, headache, prochlorperazine maleate allergy, intermittent nausea, jaw pain, penicillin allergy and T-cell lymphoma. The patient's medical history included removed right axillary node. On 03-JAN-2013, the patient was randomized and vaccinated with the first 0.5ml subcutaneous (SC) dose of blinded therapy with V-212 study or placebo. On 08-JAN-2013, the patient had Autologous Hematopoietic Cell Transplants (HCTs). On 04-FEB-2013, the patient was vaccinated with the second 0.5ml subcutaneous (SC) dose of blinded therapy with V-212 study or placebo. On 11-MAR-2013, the patient was vaccinated with the third 0.5ml subcutaneous (SC) dose of blinded therapy with V-212 study or placebo and on 04-APR-2013, was vaccinated with the fourth 0.5ml subcutaneous (SC) dose of blinded therapy with V-212 study or placebo. Other suspect therapies included PNEUMOVAX23 (14-NOV-2013). Concomitant therapies included IMODIUM, FLAGYL, PHENERGAN, LEXAPRO, ATIVAN, ciprofloxacin, FLEXERIL and DILAUDID. On 14-NOV-2013, the patient experienced severe allergic reaction to PNEUMOVAX23 (grade 4) and was hospitalized. The site was waiting for records from hospital for more details. There was no more information reported. On 14-JAN-2013, 16-JAN-2013 and 18-JAN-2013, culture, blood (bacterial and fungal) showed no growth 6 days (normal). On 17-JAN-2013, the patient recovered from severe allergic reaction to PNEUMOVAX23 (grade 4). The reporting investigator felt that severe allergic reaction to PNEUMOVAX23 (grade 4) was not related to study therapy but related to PNEUMOVAX23. During the study, the patient was also placed on ZOFRAN (21-JAN-2013); DOC-Q-LACE (11-MAR-2013) and VICODIN (11-MAR-2013) for jaw pain. Additional information has been requested.
ITCH RASED BLANCHABLE RASH  1-2 DAYS AFTER VACINATION. OVER EXTREAMITIYS . STILL PERSIST 9 DAYS POST VACINATION
My only side effects at the time were a sore arm and fatigue lasting a few days.  However, after a week, my upper arm developed a rash and itch. It's still itchy a week later. I apply a generic hydrocortisone cream (1%) to relieve the itch. I looked up this symptom and found this article about what they call Covid Arm. https://www.health.com/condition/infectious-diseases/coronavirus/covid-arm-rash-moderna
This spontaneous report as received from a physician via a company representative refers to 4 patients of unknown age and gender. Relevant medical history and concomitant medication were not provided. On an unknown date the patients were vaccinated with ZOSTAVAX. Lot number, dose, route and frequency were not provided. On an unknown date the patients experienced shingles after receiving ZOSTAVAX. All four unspecified patients received the ZOSTAVAX from the same unspecified retail pharmacy. The representative also reported that she was unsure if this was just a "venting" physician about that particular unspecified retail pharmacy. The outcome of shingles was unknown. The reported causality was unknown. Additional information has been requested.
Client was given Pfizer Monovalent instead of a Bivalent Booster. Client waited for 30 mins self monitored in waiting area. Reported no symptoms. Client was called on 1/5/23 at 1106. Explained the error. Client reported no symptoms other then initial soreness that was relieved in the arm after 24-48 hours. Client educated on Monovalent versus Bivalent, offered Bivalent 8 weeks since date. Client states no other needs or concerns at this time.
Pt. developed hives 15 minutes after vaccination on shoulder that progressed to trunk and back.  EMS present for vaccine clinic today. EMS completed assessment and administered Benadryl 50 mg. IM. EMS continued to monitor X one hour with pt. improvement. ER transport not needed.
Fevers; Body aches; Severe migraines; Severe vomiting; Headaches; Diarrhea; The initial case was assessed as non-serious. Upon receipt of follow-up information on 27Jul2021, this case now contains all required information to be upgraded to serious.  This is a spontaneous report from a contactable consumer (patient). A non-pregnant 35-year-old female patient received the first and second doses of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), both intramuscular in left arm, on 11May2021 at 06:15 PM (18:15; at the age of 35 years) (Lot Number: EW0168, Expiration Date: Aug2021), as dose 1, single, and then on 01Jun2021 at 18:00 (06:00 PM; at the age of 35 years) (Lot Number: EW0180), as dose 2, single, for COVID-19 immunization. The patient had no medical history and concomitant medications. The patient had no known allergies. The patient was not diagnosed with COVID-19 prior vaccination. No other vaccine was administered in four weeks. The vaccine was administered in a pharmacy or drug store facility. Both doses caused extreme reactions including fevers, body aches, severe migraines, severe vomiting, headaches, and diarrhea on 12May2021 and then again on 02Jun2021. The events required visit to the physician office. The events were considered serious due to persistent or significant disability or incapacity (severe and incapacitating). The patient took medicine as treatment for migraine. The other events did not require the initiation of new medication, other treatment, or procedure. The patient was not tested for COVID-19 post vaccination. The patient was recovering from "Severe migraines". The outcome of "Headaches" and "Diarrhea" was unknown. The patient recovered with lasting effects (with sequel) from "Fever" in 2021; and recovered from the remaining events (without sequel) in 2021.
Flu shot and ZOSTAVAX given at approximately 9:45 am, about 30 min later patient called and said she threw up when she got back to her house but then felt fine. Upon follow up at 2:15pm pt reported no other problems. Patient was nervous about getting IMZ.
68 y/o received pneumococcal 13 valent conjugate vaccine on 06/30/17. Presented to PCP as a walk in with right arm pain and swelling which started Saturday morning after getting a PREVNAR 13 shot on Friday afternoon. Symptoms noted to be resolving quickly without any treatment. And erythema.
Report by parent (father) on Monday (3/11/2019) four hours after immunization administration the upper left arm began to be itchy and red, fever and swelling began after midnight, had fever on Tuesday and child was trying to scratch at arm. No fever today but still swollen, maybe less red.  No pus or discharge at site of injection. EXAM: 4"X4" moderately erythematous and mildly warm to touch swollen upper left extremity. Provider drew a border with surgical pen around erythematous area in order to monitor for next 48 hours. Prescribed AUGMENTIN ES 600mg/5ml sig. 5ml orally every 12 hours for 10 days; Diphenhydramine HCl 12.5mg/5ml sig. 6ml orally q 6 hours as needed for itch; Ibuprofen 100mg/5ml sig. 6ml orally every 8 hours as needed for pain or fever.  Instructed parent to monitor and return to clinic for increasing redness, increased swelling, return of fever.
Patient received booster today. Denies any problems with last two covid vaccines. Has pain in left arm and neck and slight blurred vision in left eye that started 15 min after vaccine.  BP 198/110 SP02 97% 90:P Temp 36.9.  Reported to pharmacist advised to give 1 Benadryl 25 mg. Patient in agreement took 25 mg Benadryl. Rechecked  BP 160/98 P 80. Patient denies being seen or calling 911. Is award to call 911 with SOB or CP or gets worse . Also states will follow up with provider on BP.
Person died on 5/9/2021, with death note listing acute and chronic respiratory failure with hypoxia, COVID-19, paroxysmal atrial fibrillation, chronic heart failure with reduced ejection fraction, follicular lymphoma, history of CABG, hyperglycemia, and type 2 diabetes.
Staring at 3:00 am 04/14/2021, I was woke up with extreme stomach cramping and diarrhea. This lasted until around 12:00 PM (noon). Body aches like the flu was until about 2:00 PM. Freezing but no fever, then sweating. Exhaustion and felt spacey. All symptoms lasted until around 2:00O PM on 04/14/2021. Arm soreness
This spontaneous report as received from a licensed practical nurse refers to a patients of unknown age and gender. There were no concomitant medications, concurrent conditions and medical history reported. On an unknown dates, an unspecified number of patients received an improperly stored dose of ROTATEQ orally, lot # K016261 exp. 23-JUN-2016 (dose, was not reported). There was no adverse effect reported. PQC was not involved. This is one from several reports received from the same reporter. Additional information has been requested.
p/2nd capsule devel skin react across cheeks & center of face; racoon mask type, suntan like; blushy, but no hives; no other sx;
Information has bee received from a 25 year old female patient with no pertinent medical history and concomitant medication who in approximately 2006 "at an unspecified time about 2 1/2 years ago by another provider was vaccinated with the first and second dose of GARDASIL. On 01-JUL-2008 the patient received the third dose of GARDASIL (frequency, therapy route and Lot# unspecified). On 03-JUL-2008, the patient developed tightness in her chest and a feeling of nausea two days after she received the third dose of GARDASIL on 01-JUL-2008. The patient has not sought treatment for the symptoms. The patient's adverse events persisted. No other symptoms or treatment reported. No other information provided. Additional information has been requested.
Received GARDASIL #2 on 5 20 2010. On 5/21/2010, developed hives, pruritis, periorbital swelling. Pre-existing condition of eczema exacerbation. As of 5/25/2010, no improvement of symptoms. Pt advised to call Dermatologist.
chills; headache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) and HEADACHE (headache) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHILLS (chills) and HEADACHE (headache). At the time of the report, CHILLS (chills) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product information was not provided by the reporter.  It was reported that the patient experienced the events overnight after receiving the COVID-19 vaccine.  Treatment information was not provided.
This is a spontaneous report from a contactable consumer. A 68-year-old female patient received a single dose of PREVNAR 13, on 31Aug2015 on left arm. The patient medical history included thyroid disorder. Concomitant medication included unspecified thyroid medication. On 01Sep2015 she had severe muscular aches, pains in back, hips and thigh muscles, severe skeletal aches, she could hardly walk like her legs were not going to support her at times. She stated that she recently had to have a wheelchair in the airport and that she is terrified. She had horrible pains through her head and neck, pain in both arms. She stated these symptoms have gotten worse. She started to feel a little better, but then events reoccurred and seemed worse. Due to all the events, she went to urgent care a couple times and visited her doctor 2 to 3 times. She saw her doctor in Oct 2015 and again a week before the report. Her doctor was referring her to a rheumatologist and it will be a few weeks until she was seen. Patient stated she never had been unhealthy, and had no issues whatsoever. She had never had muscle pain before. Blood work done on an unspecified date were "perfect". Final outcome of the events was not recovered.
Pt presents to the ED for ruptured membranes at 39 weeks gestation 2/11. Pt COVID positive upon adm. Monitor placed on pt due to mother moving around in and out of bed monitor picking up maternal HR, pt contracting every 3-5 mins. Pt feeling contractions, received one dose of stadol and epidural. Patient requested epidural states pain 10/10, pt thrashing in bed. Pt delivered vaginally 2/12, vital signs stable. Post delivery, pt feels well, denies emotional concerns. Pain is well controlled with current medications. The baby is well. Baby is feeding via breast. Pt ambulating well and tolerating a normal diet, urinating and defecating.  Denies HA, CP, SOB, Lightheadedness/dizziness, calf pain. Discharged 2/13.
This is a spontaneous report from a contactable consumer (patient) or other non HCP. A 63-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EN6206, Expiration date: unknown), dose 1, via an unspecified route of administration, administered in right arm on 08Mar2021 at 12:30 (at the age of 63-year-old) as dose 1 single for COVID-19 immunisation. Medical history included diabetes mellitus from an unknown date and unknown if ongoing, cardiac disorder from an unknown date and unknown if ongoing, cerebrovascular accident from an unknown date and unknown if ongoing, psoriasis from an unknown date and unknown if ongoing, psoriatic arthropathy from an unknown date and unknown if ongoing, splenomegaly from an unknown date and unknown if ongoing, thrombocytopenia from an unknown date and unknown if ongoing, non-alcoholic steatohepatitis from an unknown date and unknown if ongoing, platelet count decreased from an unknown date and unknown if ongoing. no past drug reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did receive an extensive list other medication within 2 weeks of COVID vaccination. The patient did not diagnose with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. On 16Mar2021 at 12:00, the patient experienced his blood sugars, blood pressure, liver enzymes and other blood chemistries doubled and have remained at this level, other blood chemistries doubled and have remained at this level. It was reported that, he had Stage 4 NASH. He was under the care of a local gastroenterologist and a liver transplant specialist. Prior to his first vaccine dose, his blood chemistries were in relatively normal range.  After his vaccine, his blood sugars, blood pressure, liver enzymes and other blood chemistries doubled and have remained at this level (since Mar2021). He has not had COVID-19. He does have cardiac issues, psoriasis, psoriatic arthritis, have had a stroke, He have low blood platelets (in the 59k range). He understands that (as there was not a lot of data out there). But wanted to report these changes. He has seen many research reports of people having COVID and liver issues/transplants. But have found none with individuals not having COVID with severe liver disease. Can this be my issue with the vaccine and my blood chemistries. The patient underwent lab tests and procedures which included blood glucose increased: increased on 16Mar2021, blood pressure measurement: increased on 16Mar2021, blood test: increased on 16Mar2021, hepatic enzyme abnormal: increased on 16Mar2021, platelet count decreased: 59k on 16Mar2021 59k range. adverse event result in patient visited doctor or other healthcare professional office/clinic visit. No treatment was received for the events. The outcome of the event was reported as unknown.
(R) arm with redness, swelling circumference of (R) arm 2 cm greater than (L) arm.
vaccine number 2 injection in right arm and complains of pain in left arm. Able to move and feel left arm.
I had the somewhat expected fever and flu like aches for 2 days after vaccine but on the third day, The lymph node on the left side by the collar bone was quite enlarged. The right followed and over the next day or so, the headache started. By day 5 the headaches were so severe I was waking up in agony during the night and on the first night of headache I was nauseated but did not vomit. At this point, almost 2 weeks since vaccine, armpit, side of neck and back of neck lymph nodes are all enlarged and the headaches continue. They are not quite as severe.  I have used hydrocodone and prescription ibuprofen for pain. I started a 6 day cycle of steroids yesterday, May 7.
Chest Pain and shortness of breath, admitted to hospital with elevated troponins and  high heart rate and blood pressure
Headache; neck pain; minor injection site pain; body aches within 24 hours; runny nose; fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 14Apr2022 at 11:45 as dose 4 (booster), single (Lot number: FH8041) at the age of 58 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Migraine" (unspecified if ongoing). Concomitant medication(s) included: VERAPAMIL. Vaccination history included: BNT162b2 (Dose Number: 3, Batch/Lot No: FF8841, Location of injection: Arm Left), administration date: 20Oct2021, when the patient was 58-year-old, for COVID-19 immunisation; Covid-19 vaccine (Dose Number:2, MANUFACTURER UNKNOWN), for COVID-19 immunisation; Covid-19 vaccine (Dose Number:1, MANUFACTURER UNKNOWN), for COVID-19 immunisation. The following information was reported: HEADACHE (non-serious) with onset 14Apr2022 at 17:30, outcome "recovering"; PAIN (non-serious) with onset 14Apr2022 at 17:30, outcome "recovering", described as "body aches within 24 hours"; FATIGUE (non-serious) with onset 14Apr2022 at 17:30, outcome "recovering"; VACCINATION SITE PAIN (non-serious) with onset 14Apr2022 at 17:30, outcome "recovering", described as "minor injection site pain"; NECK PAIN (non-serious) with onset 14Apr2022 at 17:30, outcome "recovering"; RHINORRHOEA (non-serious) with onset 14Apr2022 at 17:30, outcome "recovering", described as "runny nose". Therapeutic measures were not taken as a result of headache, neck pain, vaccination site pain, pain, rhinorrhoea, fatigue.  Additional information: facility type vaccine was workplace clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Any other medications the patient received within 2 weeks of vaccination were Ritual multi-vitamin, Verapamil 240 mg daily. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No known allergies. Device timestamp was on 15Apr2022.  No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a physician refers to a 6 month old patient of unknown gender. The patient's concurrent conditions, concomitant medications, pertinent medical history and drug reactions or allergies were not provided. On 30-MAY-2017, the patient was vaccinated with an improperly stored dose of PEDVAXHIB, lot # M046140 with expiration date on 27-SEP-2019 (dose and route of administration were not reported). Since 25-APR-2017, the administered dose of PEDVAXHIB underwent multiple temperature excursions between 32 degrees Fahrenheit and 49 degrees Fahrenheit, which lasted for 16 hours. A digital data logger was not involved in recording the excursion. No adverse effects were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA012766.
Vaccination site bruise; It is hard; Itchy; Large red spot; Covid arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Covid arm), VACCINATION SITE BRUISING (Vaccination site bruise), INDURATION (It is hard), PRURITUS (Itchy) and ERYTHEMA (Large red spot) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 013L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included CITALOPRAM, VALPROATE SEMISODIUM (DIVALPROEX), PRAVASTATIN and METOPROLOL for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Feb-2021, the patient experienced VACCINATION SITE REACTION (Covid arm), INDURATION (It is hard) and PRURITUS (Itchy). 27-Feb-2021, the patient experienced ERYTHEMA (Large red spot). On an unknown date, the patient experienced VACCINATION SITE BRUISING (Vaccination site bruise). At the time of the report, VACCINATION SITE REACTION (Covid arm), VACCINATION SITE BRUISING (Vaccination site bruise), INDURATION (It is hard), PRURITUS (Itchy) and ERYTHEMA (Large red spot) outcome was unknown.
Palpitaions in right upper chest, then pain in injection sited that extende down arm, also in opposite arm. Followed by then joint pain in shoulders, that then spread to all my joints, with intense pain in neck. Headache and then after about 4 hours after start of reaching stomach pain and nausea.
hearing loss. hearing loss is getting progressively worse. at this point I need top be looking at someone's face so I can read their lips to understand what they are saying.
Itchy arm below the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchy arm below the injection site) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itchy arm below the injection site). At the time of the report, PRURITUS (Itchy arm below the injection site) outcome was unknown. Possible      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
At around 10pm patient began having heart palpitations, dizziness, weakness, and headache. Patient also felt nauseated. She was brought to the ER for evaluation. ER felt symptoms were related to anxiety. Labs were completed, chest x-ray and EKG.
Significant redness and swelling to left upper arm starting a few hours after receiving vaccine--took three days to improve
A month after receiving the vaccine my eyelids and eyebrows were very itchy and flaky. This progressed to forehead, lips, forearms down to the tops of my hand. If I would sweat my face would burn. I called my doctor who has prescribed Cortisone 10 to help with the itching. The rash will go away but it always comes back, currently the corners of my mouth are cracked and hurting. I have been experiencing shortness of breath and heart palpitations. I have an appointment to see a dermatologist in September as I have never had anything like this before.